MedCity Update – December 2015
View this email in your browser


From Eliot Forster, MedCity’s Executive Chair

In the month since our last newsletter, we have heard the Government’s Spending Review and Autumn Statement. Likely to impact every part of our sector from basic research to big business, the funding priorities outlined so far are only top line and of course the devil will be in the detail. You can see our response to the statement so far below – I would be interested to hear your views.

On a more celebratory note, I’m delighted to let you know that MedCity has a new CEO in the form of Sarah Haywood, who has been steering the ship with great energy and success as COO. The new job title is a well-deserved recognition of the responsibility of her role, and I’m very pleased to be able to share the news with you.

December is still far from over and we have a full January to look forward to, including some major activities in partnership with the London Stock Exchange. Intro with Eliot for approval – to be added 

“UK must not lose its ability to innovate”

The UK Government’s Spending Review and Autumn Statement has set out funding priorities for the rest of this parliament, with headlines including increased funding for the Catapult network, protection of the science budget in real terms, and the creation of Research UK, a new body to work across the seven research councils. 
Read MedCity’s response

OneStart 2016 receives over 750 applications

OneStart, the world’s biggest life sciences start-up accelerator initiative, has received over 750 applications from over 50 countries for its 2016 programme, with semi-finalists announced later in December.
Read more


Find out about last year’s winning start-up

Oxford’s Electrospinning raises £400k through Angels in MedCity

The Electrospinning Company, based in Oxford, has become the third company to secure investment in the first year of Angels in MedCity, an initiative to grow a new community of angel investors focused on life sciences. The company, which develops products for regenerative medicine and cell culture, has raised £400k, bringing total investment raised through the scheme to around £2.5m so far. 

See more

London MedTech: innovation and investment trends

MedCity and SEHTA brought together a range of industry experts and entrepreneurs earlier this month at a medtech networking event to highlight how the region is leading the way in advancing healthcare and NHS innovation adoption. 

Read a blog report by Gerry Montgomery of Ashfield Meetings & Events

Meet MedCity’s new CEO

Find out more from Sarah Haywood on her future ambitions for MedCity.

Read more

Take SVB’s annual survey of innovation executives

Each year Silicon Valley Bank surveys conducts a survey of life sciences and tech executives in global innovation hubs to get their perspectives on economic, industry and government policies that affect their business. Take the survey to share your views on issues affecting your industry. 
Take the survey

Second Future of Healthcare Investor Forum

MedCity and the London Stock Exchange will host the second Future of Healthcare Investor Forum on Wednesday 27 January 2016. Confirmed participating companies include AstraZeneca, UDG Healthcare, Midatech, Abzena, Immunocore, Imperial Innovations and Horizon Discovery Group. 
Find out more

Call for entries: Health Tech & You Awards

The AXA PPP Health Tech & You Awards are now open for entries, in seven categories, each with a distinct focus. The competition aims to recognise innovators who are leading the health tech revolution for the benefit of consumers, healthcare providers and wider society. on. 

Find out more and enter

London Co-Investment Fund supports 33 companies in first year

The London Co-Investment Fund has invested £5m into 33 science and tech start-ups in the year since it was launched by Mayor Boris Johnson to boost new businesses.
Find out more about how the fund could support your businesses

Saudi Arabia is largest market for UK life sciences PhD students

Saudi Arabia is the leading international market for life sciences PhDs in the UK, according to figures from the Higher Education Statistics Agency. 

Read more

Join MedCity at Biotech Showcase 2016 in San Francisco

MedCity is a sponsor of Biotech Showcase 2016, taking place in San Francisco 11-13 January, and will host an hour-long workshop panel on the re-emergence of the London Stock Exchange as a listing venue for life sciences.

Biotech Showcase features company presentations to potential investors and partners, and companies that quote MedCity in their presenter request forms will receive a $200 discount on event registration.
Find out more and apply to present here

The evolution of CROs

Medpace’s Andrew Masih, London-based Senior Director of Clinical Operations, on how Contract Research Organisations are taking over from big pharma as training grounds for the life sciences industry. 
Read more

Coming up


Biotech Showcase 2016, EBD Group, 11-13 January
Perspectives on biotech innovation and investment in London and beyond, Sidley Austin LLP, 21 January
Drug re-purposing for rare diseases, Findacure, 29 February

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the Higher Education Funding Council for England and the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in January.


Copyright © 2015 MedCity. All rights reserved.